AEGiS-Bangkok Post: Patent law change urged: Generic drugs sought for HIV/Aids patients Bangkok PostImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Bangkok Post main menu
DonateNow
Print this article

Patent law change urged: Generic drugs sought for HIV/Aids patients

Bangkok Post - September 13, 2004
Anjira Assavanonda


The National Human Rights Commission and Aids advocacy groups have urged the government to speed up patent law amendment, or issue an executive decree to ensure better access to anti-retroviral treatments for people living with HIV/Aids.

The groups said the government should change the law so it complies with the Aug 30, 2003 Doha Declaration on Trips (Trade Related Aspects of Intellectual Property Rights) and Public Health.

In November 2001, the WTO ministerial conference in Doha allowed governments to override patents through "compulsory licensing" or "parallel imports" as provided for under Trips.

The declaration pointed to a final hurdle: the effective use of compulsory licensing by countries unable to produce their own drugs.

The Doha meeting removed this obstacle by agreeing to a case-by-case system for waiving the export limitation under Trips so countries producing generic copies of patented products under compulsory licences can export them to "eligible importing countries."

Jiraporn Limpananont, of Chulalongkorn University's faculty of pharmaceutical science, said the international mechanism already allowed developing countries to use waivers to help their people, but first a national law was needed to comply with the Doha agreement.

"The agreement was settled for a year already, yet there is no legislative move," said Ms Jiraporn. "We remind the government of its responsibility to change the law for the sake of the public."

The groups earlier proposed an amendment to article 51 of the Patent Act. If successful, Thailand would be able to import generic drugs to help treatment of Aids, cancer and heart diseases, and be able to export locally-made drugs to neighbouring countries.

"Since the prime minister made his promise to the global community that he would provide access to ARVs for all Aids patients here, and would offer help to neighbouring countries, he should do something to keep his word," said Ms Jiraporn.

About one million Thais are living with HIV/Aids, and of the 100,000 classified as patients, only about 5% receive anti-retroviral drugs.

Assoc Prof Phijaisakdi Horayangkura, of Chulalongkorn University's faculty of law, said the groups should push the government to issue an executive decree instead. The HIV/Aids problem could be considered an emergency, justifying such a short-track measure, he said.


040913
BP040903


Copyright © 2004 - The Bangkok Post. Reproduction of this article (other than one copy for personal reference) must be cleared through the Bangkok Post.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .